Distribution Study of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and Its Metabolites in Rats
INTRODUCTION. This article continues a series of publications on the pharmacokinetics of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide (TFISA), a novel compound for the treatment of open-angle glaucoma. The distribution of TFISA and its metabolites in rat organs and tissues has not be...
Saved in:
Main Authors: | I. I. Yaichkov, A. L. Khokhlov, M. K. Korsakov, N. N. Volkhin, S. S. Petukhov, O. E. Lazariants, A. V. Korovina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2025-07-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/743 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Excretion Study of 5-[5-(Trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide in Rats
by: I. I. Yaichkov, et al.
Published: (2023-08-01) -
Development and validation of the method of quantification of 5-[5-(trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide and its metabolites in laboratory animal plasma
by: I. I. Yaichkov, et al.
Published: (2024-09-01) -
Study of biotransformation of new selective carbonic anhydrase II inhibitor 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide
by: A. L. Khokhlov, et al.
Published: (2023-11-01) -
Pharmacokinetics Study of a New Isoxazole Derivative in Rats Using HPLC-MS/MS for Blood Sample Analysis
by: I. I. Yaichkov, et al.
Published: (2024-07-01) -
Prospects for the application of inhibitors of carbonic anhydrase isoforms IX and XII in oncology
by: S. А. Kalinin, et al.
Published: (2024-04-01)